Log in to post a reply
May 6, 2022 06:33PM
susaninsf
wrote:
I agree with parakeetsrule. The main reason to get a thoracentesis even if you don't have symptoms is so that your lung will reinflate. After three years, reinflation is unlikely. Since you aren't experiencing any symptoms, that's seems ok. How much fluid was taken out the last time you had a Thoracentesis?
Wonderful that you no longer have any active lung nodes. Your pleural effusion should not get worse if your disease is minimal and stable.
Hugs, Susan
Mets to brain, lung, liver, eye, femur bone.
Dx
2000, DCIS, <1cm, Stage 0, Grade 3, 0/2 nodes, ER+/PR+, HER2-
Surgery
8/31/2000 Lumpectomy; Lumpectomy (Left); Lumpectomy (Right); Lymph node removal; Lymph node removal (Right): Sentinel; Reconstruction (Right)
Dx
2008, DCIS, <1cm, Stage 0, Grade 3, 0/2 nodes, ER+/PR+, HER2-
Surgery
3/2/2008 Mastectomy; Mastectomy (Right)
Dx
3/29/2014, DCIS, Left, 4cm, Stage IV, metastasized to brain/bone/lungs/other, mets, ER+/PR-, HER2-
Hormonal Therapy
3/31/2014 Tamoxifen pills (Nolvadex, Apo-Tamox, Tamofen, Tamone)
Radiation Therapy
4/28/2014 External
Local Metastases
4/28/2014 Brain
Chemotherapy
10/30/2014 Xeloda (capecitabine)
Radiation Therapy
1/8/2015 External
Local Metastases
1/8/2015 Radiation therapy: Bone
Radiation Therapy
6/6/2016 External
Hormonal Therapy
11/16/2016 Faslodex (fulvestrant)
Targeted Therapy
12/21/2016 Ibrance (palbociclib)
Radiation Therapy
11/27/2017 External
Local Metastases
11/27/2017 Brain
Hormonal Therapy
8/21/2018 Femara (letrozole)
Targeted Therapy
8/21/2018 Piqray (alpelisib)
Chemotherapy
4/23/2019 Taxol (paclitaxel)
Chemotherapy
6/19/2019 Abraxane (albumin-bound or nab-paclitaxel)
Radiation Therapy
10/23/2019 External
Local Metastases
10/23/2019 Brain
Immunotherapy
10/25/2019
Targeted Therapy
2/18/2020 Trodelvy (sacituzumab govitecan-hziy)
Dx
3/8/2021, Stage IV, metastasized to liver
Hormonal Therapy
3/12/2021 Aromasin (exemestane)
Targeted Therapy
3/16/2021 Verzenio
Chemotherapy
9/8/2021 Other
Chemotherapy
11/2/2021 Other
Targeted Therapy
1/6/2022
Targeted Therapy
6/24/2022 Enhertu (fam-trastuzumab deruxtecan-nxki)